Palisades Investment Partners, LLC

Position in TVTX — Travere Therapeutics, Inc.

CIK 1427373 SANTA MONICA, CA

Position in TVTX

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$15,513,674

+$7,930,494 QoQ

Shares Held

273,080

+7.0% QoQ

Ownership

0.290%

of shares outstanding

% of Portfolio

4.28%

of 13F equity value

Holder Rank

#61

of 317 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 84% Shared 0% None 16%

Healthcare · as of Jun 30, 2026

Palisades Investment Partners, LLC holds $36,628,233 across 3 Biotechnology names. TVTX ranks #2 (42.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KRYS	Krystal Biotech, Inc.	47,801	$17,766,197
2	TVTX	Travere Therapeutics, Inc. This page	273,080	$15,513,674
3	CRMD	CorMedix Inc.	426,543	$3,348,362

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$15,513,674	273,080	+7.0%	Shares	Sole	2026-08-04
2026-03-31	$7,583,180	255,240	+85.3%	Shares	Sole	2026-04-30
2025-12-31	$5,264,115	137,768	—	Shares	Sole	2026-01-20
No filing history on record for this holder in this stock.